SOHM, Inc. develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States. The company offers analgesics, antibiotics, anti-cold, and anti-inflammatory drugs, as well as over-the-counter, cosmeceuticals, and nutraceutical products. It also exports its products. The company has collaboration agreement with Coastar Therapeutics to advance in the field of genome editing using red blood cell membrane derived carriers and genome editing technology. SOHM, Inc. was founded in 2005 and is based in Corona, California.
Frequently asked questions
What sector does Sohm Inc. (SHMN) operate in?
Sohm Inc. belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Sohm Inc. (SHMN) current stock price?
As of the latest data, Sohm Inc. stock price is $0.00, with a previous close of $0.00.
What is Sohm Inc. (SHMN) current market capitalization?
Sohm Inc. market cap is approximately 2.03 million.
What is Sohm Inc. (SHMN) Earnings Per Share (EPS)?
The trailing EPS is -$0.00.
What is Sohm Inc. (SHMN) EBITDA?
Sohm Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -97.85 thousand.
Does Sohm Inc. (SHMN) pay dividends?
No. Sohm Inc. does not pay a dividend.
What is Sohm Inc. (SHMN) beta (volatility) score?
Sohm Inc. has a beta of 0.978, meaning its volatility is roughly in line with the market.